To hear about similar clinical trials, please enter your email below
Trial Title:
Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
NCT ID:
NCT01627093
Condition:
Head and Neck Carcinoma
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Other
Intervention:
Intervention type:
Other
Intervention name:
Medical Chart Review
Description:
Review of medical records
Arm group label:
Observational (questionnaire, medical chart review)
Other name:
Chart Review
Intervention type:
Other
Intervention name:
Questionnaire Administration
Description:
Complete questionnaires
Arm group label:
Observational (questionnaire, medical chart review)
Summary:
This trial collects medical information from patients with head and neck cancer that have
received or are scheduled to receive proton therapy. Collecting and analyzing medical
information from patients may provide information on the outcomes and treatment related
side effects of proton therapy for head and neck cancer and help doctors improve therapy
for future patients with head and neck cancer.
Detailed description:
PRIMARY OBJECTIVE:
I. To evaluate the outcomes in patients who have received treatment for their head and
neck malignancy with proton radiation therapy.
OUTLINE:
Patients complete questionnaires over 30 minutes before treatment begins, at each visit
during treatment, and again at all follow-up visits related to treatment. Patients also
have their medical records reviewed.
Criteria for eligibility:
Study pop:
Patients documented to have head and neck cancer treated with proton therapy at MD
Anderson Cancer Center in Houston, Texas (MDACC) from January 1, 2008 through April 30,
2012, and patients who receive treatment from May 1, 2012 through December 31, 2018
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients documented to have head and neck cancer treated with proton therapy at
MDACC from January 1, 2008 through April 30, 2012 and patients who receive treatment
from May 1, 2012 through December 31, 2018
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
M D Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Start date:
January 6, 2012
Completion date:
April 30, 2026
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01627093
http://www.mdanderson.org
